Key facts
- This page summarizes Stephen Christopher Linthwaite's Form 4 filing for FLUIDIGM CORP (LAB).
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2022, 16:16.
Stephen Christopher Linthwaite - 22 Feb 2022 Form 4 Insider Report for FLUIDIGM CORP (LAB)
- Reporting relationship
- President & CEO
- Issuer ticker
- LAB
- Reported as of
- 22 Feb 2022
- Net transaction value
- -$45,123
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2022, 16:16:46 UTC
- Prior SEC filing
- 24 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Christopher Linthwaite by Nicholas Khadder, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stephen Christopher Linthwaite filed Form 4 for FLUIDIGM CORP (LAB) on 24 Feb 2022.
Change
- Previous filing in this sequence was filed on 24 Nov 2021.
- Current net transaction value: -$45,123.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,813
- Change %
- +2.5%
- Price
- $0.000000
- Shares after
- 326,334
- Date
- 22 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +6,882
- Change %
- +2.1%
- Price
- $0.000000
- Shares after
- 333,216
- Date
- 22 Feb 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,722
- Change %
- +2.3%
- Price
- $0.000000
- Shares after
- 340,938
- Date
- 22 Feb 2022
- Ownership
- Direct
LAB
transaction
Common Stock
Tax liability
- Transaction value
- $45,123
- Shares
- -12,465
- Change %
- -3.7%
- Price
- $3.62
- Shares after
- 328,473
- Date
- 22 Feb 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,813
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 7,813
- Date
- 22 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,813
- Exercise price
- Footnotes
- F2, F3
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,882
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 27,528
- Date
- 22 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,882
- Exercise price
- Footnotes
- F2, F4
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,722
- Change %
- -11%
- Price
- $0.000000
- Shares after
- 61,779
- Date
- 22 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,722
- Exercise price
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan.
Footnote F2
Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
Footnote F3
On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.
Footnote F4
On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
Footnote F5
On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.